Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps-Reference-Cited by-同舟云学术

Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps

Published:2022-12 Issue:12 Volume:15 Page:100721
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Bagnasco Diego,Canevari Rikki Frank,Del Giacco Stefano,Ferrucci Silvia,Pigatto Paolo,Castelnuovo Paolo,Marseglia Gian Luigi,Yalcin Arzu Didem,Pelaia Girolamo,Canonica Giorgio Walter

Funder

Novartis Farmacéutica

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference13 articles.

1. Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: a nine-year study;Di Bona;Respir Med,2017

2. Omalizumab in the treatment of chronic inducible urticaria;Chicharro;Actas Dermosifiliogr,2017

3. Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials;Wu;BMJ Open,2021

4. AllergoOncology - the impact of allergy in oncology: EAACI position paper;Jensen-Jarolim;Allergy,2017

5. Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab;Long;J Allergy Clin Immunol,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial;Frontiers in Immunology;2024-07-29

2. Omalizumab for management of hypersensitivity reactions to anticancer drugs;Internal Medicine Journal;2024-07-19

3. Real-World Safety Profile of Biologic Drugs for Severe Uncontrolled Asthma: A Descriptive Analysis from the Spanish Pharmacovigilance Database;Journal of Clinical Medicine;2024-07-18

4. Biologic Therapies across Nasal Polyp Subtypes;Journal of Personalized Medicine;2024-04-19

5. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database;BioDrugs;2024-03-15